These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11364207

  • 1. Nelfinavir at six months.
    PI Perspect; 1997 Mar; (No 21):11-2. PubMed ID: 11364207
    [Abstract] [Full Text] [Related]

  • 2. Nelfinavir - major trial results at retroviruses conference.
    AIDS Treat News; 1997 Feb 21; (No 265):3-4. PubMed ID: 11364240
    [Abstract] [Full Text] [Related]

  • 3. Phase II/III Trials of Viracept start.
    AIDS Patient Care STDS; 1996 Jun 21; 10(3):187. PubMed ID: 11361632
    [No Abstract] [Full Text] [Related]

  • 4. Nelfinavir (Viracept).
    Baker R, Bowers M.
    BETA; 1997 Mar 21; ():5. PubMed ID: 11364528
    [Abstract] [Full Text] [Related]

  • 5. Newly approved PI provides treatment options.
    AIDS Alert; 1997 Jun 21; 12(6):68-9. PubMed ID: 11364360
    [Abstract] [Full Text] [Related]

  • 6. Nelfinavir combination therapy: ten-month report.
    AIDS Treat News; 1997 Apr 18; (No 269):3. PubMed ID: 11364253
    [Abstract] [Full Text] [Related]

  • 7. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1997 Jun 18; 3(6):17-21. PubMed ID: 11364427
    [Abstract] [Full Text] [Related]

  • 8. New drug approved to treat HIV.
    Treat Rev; 1997 Apr 18; (No 24):5. PubMed ID: 11364284
    [Abstract] [Full Text] [Related]

  • 9. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B.
    Posit Aware; 1997 Apr 18; 8(2):16-7. PubMed ID: 11364452
    [Abstract] [Full Text] [Related]

  • 10. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
    James JS.
    AIDS Treat News; 1997 Mar 21; (No 267):1-2. PubMed ID: 11364249
    [Abstract] [Full Text] [Related]

  • 11. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar 21; 11(3):8. PubMed ID: 11364277
    [Abstract] [Full Text] [Related]

  • 12. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997 Mar 21; (No 32):31-2. PubMed ID: 11364442
    [Abstract] [Full Text] [Related]

  • 13. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 21; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P, Likanonsakul S.
    Southeast Asian J Trop Med Public Health; 2002 Jun 21; 33(2):280-7. PubMed ID: 12236426
    [Abstract] [Full Text] [Related]

  • 15. Antiretroviral rounds. When success is a pain.
    Bartlett JG, del Rio C.
    AIDS Clin Care; 2001 Aug 21; 13(8):74-5. PubMed ID: 11547461
    [No Abstract] [Full Text] [Related]

  • 16. HIV-1 protease inhibitors.
    Deeks SG, Volberding PA.
    AIDS Clin Rev; 2001 Aug 21; ():145-85. PubMed ID: 9305448
    [No Abstract] [Full Text] [Related]

  • 17. Anti-HIV effects of Viracept persist during long periods of combination therapy.
    Oncology (Williston Park); 1997 Jun 21; 11(6):915. PubMed ID: 9189946
    [No Abstract] [Full Text] [Related]

  • 18. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar 10; 14(4):367-74. PubMed ID: 10770538
    [Abstract] [Full Text] [Related]

  • 19. FDA rapidly approves HIV protease inhibitors for children.
    Fox JL.
    Nat Biotechnol; 1997 May 10; 15(5):404. PubMed ID: 9131607
    [No Abstract] [Full Text] [Related]

  • 20. New protease inhibitor for children.
    Vazquez E.
    Posit Aware; 1997 May 10; 8(2):11. PubMed ID: 11364449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.